Tariquidar

DB06240InvestigationalSmall molecule

Investigated for use/treatment in ovarian cancer, lung cancer, and breast cancer.

Chemical structure of Tariquidar
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in ovarian cancer, lung cancer, and breast cancer.Curator reviewed
Formula / weight
C38H38N4O6 · 646.744 g/mol (avg)
Code names
XR-9576

Resolves to

Structure
InChIKeyLGGHDPFKSSRQNS-UHFFFAOYSA-NSMILESCOC1=CC2=C(CN(CCC3=CC=C(NC(=O)C4=CC(OC)=C(OC)C=C4NC(=O)C4=CN=C5C=CC=CC5=C4)C=C3)CC2)C=C1OC
Transporters

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
164Drug interactionsStructured to mechanism, not free text
Sign in
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tariquidar, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account